Stock Market

Stocks making the biggest moves after hours: Workday, CrowdStrike, Horizon Therapeutics and more

In this article

CrowdStrike IPO at the Nasdaq exchange June 12, 2019.
Source: Nasdaq

Check out the companies making headlines in after-hours trading.

Workday — Workday gained 6% postmarket Tuesday after earnings beat Wall Street estimates on both the top- and bottom lines. The software vendor reported adjusted earnings per share of 99 cents on $1.6 billion in revenue, where analysts expected adjusted earnings of 84 cents per share and $1.59 billion in revenue, per Refinitiv.

CrowdStrike — CrowdStrike Holdings plunged more than 18% after giving light guidance for fourth-quarter revenue. In the quarter just ended, results topped earnings and revenue expectations, with the cybersecurity provider posting adjusted earnings per share of 40 cents on $581 million in revenue where analysts expected adjusted earnings of 31 cents per share on $574 million in revenue, per Refinitiv.

NetApp — NetApp stock fell 10.8% after cloud services and data management provider saw weaker-than-expected revenue in its latest quarter. NetApp reported adjusted earnings per share of $1.48, beating estimates of $1.33. But its revenue of $1.66 billion fell short of the $1.68 billion Wall Street anticipated, per Refinitiv. NetApp also issued weak forward guidance.

HP Enterprise — HP Enterprise rose 2.2% after the company beat earnings estimates on the top and bottom lines. HPE adjusted earnings per share of 57 cents on $7.87 billion in revenue surpassed Wall Street estimates of 56 cents and $7.42 billion, respectively, per Refinitiv.

AST SpaceMobile — Shares of AST SpaceMobile fell 10.7% after the satellite maker set plans to sell $65 million of Class A common stock. Proceeds will be used for general corporate purposes.

Horizon Therapeutics — The biotech shot up 36% after hours after Dow Jones reported that the $18 billion biotech is fielding takeover interest. Dow Jones cited unnamed people familiar with the matter.

Articles You May Like

Should You Buy Biotech ETFs Now?
Synaptics (SYNA) and NeoPhotonics (NPTN) are Aggressive Growth Stocks
Gilead’s Stock is on Sale: Should You Buy?
Puerto Rico’s December revenues 28% ahead of projections
Do Dogecoin’s (DOGE) and Shiba Inu’s (SHIB) stalled rallies mean the memecoin trend is dead?